aVaxzipen

aVaxziPen is using its aVaxziPen™ technology to develop a range of innovative needle-free injectable solid dose vaccine products with potential to transform the performance and delivery of vaccines and make a material impact on global healthcare, and we are already making great progress.

Our primary focus is the development of novel solid dose vaccines against a range of infectious and other select diseases, working in partnership with global companies, government agencies and non-governmental organisations.

Clients include the largest vaccine companies, challenger vaccine companies, specialist biotech developers and key governments.  We also have several opportunities in animal health.